Associated Papers
Characterization of genetic variants of GIPR reveals a contribution of β-arrestin to metabolic phenotypes.
Kizilkaya HS et al.
Nature Metabolism, 2024
38871982 (PubMed )
Supplement: 42255_2024_1061_MOESM11_ESM.xlsx › ED_Fig._1a-b
Evaluation of a rare glucose-dependent insulinotropic polypeptide receptor variant in a patient with diabetes.
Jacobi SF et al.
Diabetes, Obesity & Metabolism, 2019
[The role of single nucleotide polymorphisms in GIPR gene in the changes of secretion in hormones and adipokines in patients with obesity with type 2 diabetes].
Skuratovskaia DA et al.
Biomeditsinskaia Khimiia, 2018
Pharmacological characterization of human incretin receptor missense variants.
Fortin JP et al.
The Journal of Pharmacology and Experimental Therapeutics, 2010
Typical Danish Caucasian type 2 diabetic patients do not commonly carry genetic variants in GIP and GLP-1 encoding regions of the proGIP and proglucagon genes.
Ørskov C et al.
Regulatory Peptides, 2004
Discovery of amino acid variants in the human glucose-dependent insulinotropic polypeptide (GIP) receptor: the impact on the pancreatic beta cell responses and functional expression studies in Chinese hamster fibroblast cells.
Almind K et al.
Diabetologia, 1998
Select a paper to view details